Stem Point Capital LP Immatics N.V. Transaction History
Stem Point Capital LP
- $378 Billion
- Q1 2024
A detailed history of Stem Point Capital LP transactions in Immatics N.V. stock. As of the latest transaction made, Stem Point Capital LP holds 491,926 shares of IMTX stock, worth $5.81 Million. This represents 1.37% of its overall portfolio holdings.
Number of Shares
491,926
Previous 1,020,214
51.78%
Holding current value
$5.81 Million
Previous $10.7 Billion
51.87%
% of portfolio
1.37%
Previous 2.87%
Shares
2 transactions
Others Institutions Holding IMTX
# of Institutions
85Shares Held
68.8MCall Options Held
507KPut Options Held
170K-
Rtw Investments, LP New York, NY10MShares$118 Million1.69% of portfolio
-
Wellington Management Group LLP Boston, MA8.33MShares$98.4 Million0.02% of portfolio
-
Baker Bros. Advisors LP New York, NY6.44MShares$76.2 Million0.86% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.3MShares$74.5 Million0.04% of portfolio
-
Perceptive Advisors LLC New York, NY4.58MShares$54.2 Million1.01% of portfolio
About Immatics N.V.
- Ticker IMTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,227,000
- Market Cap $901M
- Description
- Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor (TCR) based immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive c...